Remodeling as an End-Point in Heart Failure Therapy

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.18, Iss.1, 2004-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Modulation of Cardiovascular Remodeling: A Guide to Heart Failure Therapy

By Remme W.J.

Cardiovascular Drugs and Therapy, Vol. 17, Iss. 4, 2003-07 ,pp. : 349-360

Springer Publishing Company

Access to resources Recommend Favorite

Allopurinol or Oxypurinol in Heart Failure Therapy – a Promising New Development or End of Story?

By Reyes Ariel Leary William

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 5, 2005-10 ,pp. : 311-313

Springer Publishing Company

Access to resources Recommend Favorite

Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction

By Sanganalmath Santosh K. Barta Judit Takeda Nobuakira Kumamoto Hideo Dhalla Naranjan S.

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 4, 2008-04 ,pp. : 180-189

NRC Research Press

Access to resources Recommend Favorite

Role of MicroRNAs in Cardiac Remodeling and Heart Failure

By Topkara Veli

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 2, 2011-04 ,pp. : 171-182

Springer Publishing Company

Access to resources Recommend Favorite

Energy Remodeling, Mitochondrial Disorder and Heart Failure

Current Pharmaceutical Design, Vol. 22, Iss. 31, 2016-09 ,pp. : 4823-4829

Bentham Science Publishers

Access to resources Recommend Favorite